Cambridge Investment Research Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.2M | Buy |
144,124
+536
| +0.4% | +$70.6K | 0.04% | 445 |
|
|
2026
Q1 | $20M | Buy |
143,588
+3,267
| +2% | +$457K | 0.05% | 379 |
|
|
2025
Q4 | $17.2M | Sell |
140,321
-21,522
| -13% | -$2.62M | 0.05% | 409 |
|
|
2025
Q3 | $18M | Sell |
161,843
-1,003
| -0.6% | -$114K | 0.05% | 382 |
|
|
2025
Q2 | $18.1M | Sell |
162,846
-27,927
| -15% | -$2.97M | 0.05% | 347 |
|
|
2025
Q1 | $21.4M | Buy |
190,773
+38,530
| +25% | +$3.98M | 0.07% | 272 |
|
|
2024
Q4 | $14.1M | Buy |
152,243
+16,375
| +12% | +$1.47M | 0.05% | 381 |
|
|
2024
Q3 | $11.4M | Sell |
135,868
-42,455
| -24% | -$3.24M | 0.04% | 453 |
|
|
2024
Q2 | $12.2M | Buy |
178,323
+705
| +0.4% | +$47K | 0.05% | 401 |
|
|
2024
Q1 | $13M | Sell |
177,618
-42,376
| -19% | -$3.26M | 0.05% | 363 |
|
|
2023
Q4 | $17.8M | Buy |
219,994
+17,774
| +9% | +$1.38M | 0.08% | 257 |
|
|
2023
Q3 | $15.2M | Buy |
202,220
+64,569
| +47% | +$4.97M | 0.07% | 268 |
|
|
2023
Q2 | $10.6M | Sell |
137,651
-5,255
| -4% | -$419K | 0.05% | 370 |
|
|
2023
Q1 | $11.9M | Sell |
142,906
-1,016
| -0.7% | -$84.2K | 0.06% | 325 |
|
|
2022
Q4 | $12.4M | Sell |
143,922
-17,588
| -11% | -$1.39M | 0.06% | 307 |
|
|
2022
Q3 | $9.96M | Buy |
161,510
+5,043
| +3% | +$318K | 0.06% | 330 |
|
|
2022
Q2 | $9.67M | Buy |
156,467
+5,519
| +4% | +$342K | 0.05% | 342 |
|
|
2022
Q1 | $8.97M | Buy |
150,948
+1,625
| +1% | +$104K | 0.04% | 413 |
|
|
2021
Q4 | $10.8M | Sell |
149,323
-3,502
| -2% | -$241K | 0.05% | 356 |
|
|
2021
Q3 | $10.7M | Sell |
152,825
-6,875
| -4% | -$483K | 0.05% | 339 |
|
|
2021
Q2 | $11M | Sell |
159,700
-303
| -0.2% | -$20.2K | 0.05% | 341 |
|
|
2021
Q1 | $10.3M | Buy |
160,003
+4,751
| +3% | +$306K | 0.06% | 328 |
|
|
2020
Q4 | $9.04M | Sell |
155,252
-3,656
| -2% | -$221K | 0.05% | 327 |
|
|
2020
Q3 | $10M | Sell |
158,908
-69,040
| -30% | -$4.79M | 0.07% | 272 |
|
|
2020
Q2 | $17.5M | Sell |
227,948
-29,472
| -11% | -$2.26M | 0.13% | 165 |
|
|
2020
Q1 | $19.2M | Buy |
257,420
+136,590
| +113% | +$9.44M | 0.18% | 119 |
|
|
2019
Q4 | $7.85M | Buy |
120,830
+15,144
| +14% | +$986K | 0.06% | 316 |
|
|
2019
Q3 | $6.7M | Sell |
105,686
-8,467
| -7% | -$553K | 0.06% | 314 |
|
|
2019
Q2 | $7.71M | Sell |
114,153
-22,517
| -16% | -$1.48M | 0.07% | 268 |
|
|
2019
Q1 | $8.88M | Sell |
136,670
-87
| -0.1% | -$5.78K | 0.09% | 230 |
|
|
2018
Q4 | $8.55M | Sell |
136,757
-10,096
| -7% | -$706K | 0.09% | 208 |
|
|
2018
Q3 | $11.3M | Sell |
146,853
-8,466
| -5% | -$639K | 0.11% | 187 |
|
|
2018
Q2 | $11M | Sell |
155,319
-8,907
| -5% | -$629K | 0.12% | 172 |
|
|
2018
Q1 | $12.4M | Sell |
164,226
-37,696
| -19% | -$3M | 0.14% | 147 |
|
|
2017
Q4 | $14.5M | Buy |
201,922
+8,351
| +4% | +$634K | 0.17% | 123 |
|
|
2017
Q3 | $15.7M | Buy |
193,571
+4,028
| +2% | +$308K | 0.21% | 95 |
|
|
2017
Q2 | $13.4M | Sell |
189,543
-2,135
| -1% | -$142K | 0.2% | 102 |
|
|
2017
Q1 | $13M | Buy |
191,678
+57,423
| +43% | +$4.04M | 0.22% | 93 |
|
|
2016
Q4 | $9.61M | Buy |
134,255
+11,333
| +9% | +$842K | 0.18% | 112 |
|
|
2016
Q3 | $9.73M | Buy |
122,922
+14,341
| +13% | +$1.16M | 0.18% | 104 |
|
|
2016
Q2 | $9.06M | Buy |
108,581
+4,167
| +4% | +$370K | 0.19% | 105 |
|
|
2016
Q1 | $9.59M | Buy |
104,414
+2,557
| +3% | +$231K | 0.22% | 93 |
|
|
2015
Q4 | $10.3M | Buy |
101,857
+6,154
| +6% | +$640K | 0.24% | 89 |
|
|
2015
Q3 | $9.4M | Buy |
95,703
+11,749
| +14% | +$1.3M | 0.27% | 78 |
|
|
2015
Q2 | $9.83M | Buy |
83,954
+15,468
| +23% | +$1.69M | 0.27% | 81 |
|
|
2015
Q1 | $6.72M | Buy |
68,486
+14,982
| +28% | +$1.52M | 0.19% | 106 |
|
|
2014
Q4 | $5.04M | Buy |
53,504
+7,561
| +16% | +$782K | 0.16% | 131 |
|
|
2014
Q3 | $4.89M | Buy |
45,943
+3,158
| +7% | +$309K | 0.14% | 145 |
|
|
2014
Q2 | $3.55M | Buy |
42,785
+15,243
| +55% | +$1.19M | 0.12% | 154 |
|
|
2014
Q1 | $1.95M | Sell |
27,542
-1,055
| -4% | -$82.7K | 0.07% | 266 |
|
|
2013
Q4 | $2.15M | Buy |
28,597
+5,668
| +25% | +$395K | 0.09% | 217 |
|
|
2013
Q3 | $1.44M | Buy |
22,929
+2,976
| +15% | +$178K | 0.06% | 277 |
|
|
2013
Q2 | $1.02M | Buy |
+19,953
| New | +$1.04M | 0.05% | 317 |
|
Other funds holding GILD
Cambridge Investment Research Advisors's GILD Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Gilead Sciences (GILD) stake by 0.37% in Q2 2026, buying an estimated $70.6K and bringing the position to 144,124 shares worth $18.2M. The position accounts for 0.04% of the portfolio, ranked #445.
Cambridge Investment Research Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.4M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Cambridge Investment Research Advisors held 144,124 shares of Gilead Sciences worth $18.2M as of Q2 2026.
- Cambridge Investment Research Advisors bought 536 Gilead Sciences shares in Q2 2026, an estimated $70.6K.
- Gilead Sciences made up 0.04% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #445 holding.
- Cambridge Investment Research Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Cambridge Investment Research Advisors's Gilead Sciences position peaked at $21.4M in Q1 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.